These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Balfour JA, McTavish D. Drugs; 1993 Dec; 46(6):1025-54. PubMed ID: 7510610 [Abstract] [Full Text] [Related]
6. Comparative tolerability profiles of oral antidiabetic agents. Krentz AJ, Ferner RE, Bailey CJ. Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543 [Abstract] [Full Text] [Related]
7. A review of the safety and efficacy of acarbose in diabetes mellitus. Yee HS, Fong NT. Pharmacotherapy; 1996 Oct; 16(5):792-805. PubMed ID: 8888075 [Abstract] [Full Text] [Related]
10. The use of acarbose in the prevention and treatment of hypoglycaemia. Lefebvre PJ, Scheen AJ. Eur J Clin Invest; 1994 Aug; 24 Suppl 3():40-4. PubMed ID: 8001627 [Abstract] [Full Text] [Related]
11. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes. Welborn TA. Med J Aust; 1998 Jan 19; 168(2):76-8. PubMed ID: 9469188 [No Abstract] [Full Text] [Related]
12. [Alpha-glucosidase inhibitors: a new therapeutic approach in diabetes and functional hypoglycemia]. Brogard JM, Willemin B, Blicklé JF, Lamalle AM, Stahl A. Rev Med Interne; 1989 Jan 19; 10(4):365-74. PubMed ID: 2678346 [Abstract] [Full Text] [Related]
13. Clinical experience with acarbose as first line therapy in NIDDM. Fölsch UR. Clin Invest Med; 1995 Aug 19; 18(4):312-7. PubMed ID: 8549018 [Abstract] [Full Text] [Related]
14. The mechanism of alpha-glucosidase inhibition in the management of diabetes. Bischoff H. Clin Invest Med; 1995 Aug 19; 18(4):303-11. PubMed ID: 8549017 [Abstract] [Full Text] [Related]